跳至主要内容
临床试验/NCT01612702
NCT01612702已完成4 期

The Use of a Single, Low-dose Dexamethasone in Total Knee Arthroplasty

Tae Kyun Kim1 个研究点 分布在 1 个国家目标入组 291 人开始时间: 2011年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
291
试验地点
1
主要终点
Incidence of Nausea and Vomiting

研究概览

简要总结

This study was conducted to determine the efficacy of an additional preemptive, single, low-dose dexamethasone in terms of incidence and severity of postoperative nausea/vomiting (PONV), pain level, and the safety in terms of wound complications in patients managed with our antiemetic protocol based on Ramosetron following TKA.

详细描述

Postoperative pain and emesis can cause postoperative systemic complications and delay recovery and rehabilitation in patients following total knee arthroplasty (TKA). Furthermore, patients who suffered from severe postoperative pain and emesis tend to be dissatisfied with their surgical treatments. Although contemporary protocols to control perioperative pain and emesis after TKA have been reported to substantially reduce postoperative pain and emesis compared with traditional measures, pain and emesis after TKA remain to be a challenging issue for patients and health care providers. In our previous study, the use of Ramosetron was found to reduce postoperative emetic events, but the antiemetic effects by Ramosetron were incomplete. In search of a further antiemetic measure, we identified the use of dexamethasone as the additional measure fortifying our antiemetic protocol using Ramosetron.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of primary osteoarthritis, knee
  • Scheduled for elective total knee arthroplasty
  • Signed written informed consent

排除标准

  • Refusing participate
  • Contraindication to regional anesthesia
  • Severe impairment of bowel motility
  • administration of other antiemetic drug within 24hours before surgery
  • systemic steroid within 24hours before surgery
  • history of cardiovascular & respiratory disease
  • renal & hepatic failure

研究组 & 干预措施

Dexamethasone

Experimental

dexamethasone 10 mg administration 1 hour before surgery

干预措施: Dexamethasone (Drug)

结局指标

主要结局

Incidence of Nausea and Vomiting

时间窗: within 72 hours after surgery

A clinical investigator who is blinded to randomization assessed the incidence of postoperative nausea which defined as subjective unpleasant sensation associated with awareness of the urge to vomit and as emetic episode and vomiting

次要结局

  • Pain Level(6 to 24 hours after surgery)
  • Wound Complication(within 30 days after surgery)

研究者

发起方
Tae Kyun Kim
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Tae Kyun Kim

Direcor, Joint reconstruction center, SNUBH

Seoul National University Hospital

研究点 (1)

Loading locations...

相似试验

Efficacy and Safety of Single, Low-dose... | 临床试验